#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage III Neuroendocrine carcinoma Thymic carcinoma Obliterative bronchiolitis Immune-mediated renal disorder T-cell type acute leukaemia Keratosis follicular Cluster headache Acute graft versus host disease Facioscapulohumeral muscular dystrophy Osteomyelitis Neuronal ceroid lipofuscinosis Neurodermatitis Glioblastoma multiforme B-cell small lymphocytic lymphoma recurrent More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Life with Disease Ewing’s sarcoma Noonan syndrome – Life with Disease Osteosarcoma recurrent – Life with Disease IgA nephropathy SAPHO syndrome – Treatment Activated PI3 kinase delta syndrome – Trials in Disease Glomerulonephritis membranous – Life with Disease Friedreich’s ataxia – Diagnostics Ehlers-Danlos syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eprosartan Mesilate Carcik-Cd19 Cells Benzalkonium Chloride Testosterone Undecanoate Taurine Tafasitamab Tofacitinib Citrate Mercaptopurine Mirtazapine Batoclimab Remimazolam Pemafibrate Apixaban Poloxamer 407 Dalteparin Sodium Tabelecleucel Munc-Cd34 Trometamol Diltiazem Hydrochloride Cyanocobalamin More therapies…

    Learn about Your Condition

    Alveolar bone defect Irritable bowel syndrome Chronic sinusitis Hyperadrenocorticism Endocrine ophthalmopathy Pancreaticoduodenectomy HER2 protein overexpression Ankylosing spondylitis Bronchostenosis Myeloid leukaemia Noninfective chorioretinitis Urticaria chronic Epiphysiolysis Optic atrophy Rhabdoid tumour of the kidney More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Sirolimus Cream for Patients with Port Wine Stains

    Recruiting

    2 1 1
    Investigated Diseases:
    • Naevus flammeus
    Investigated Drugs:
    • Sirolimus
    Spain

  • Study of Mesenchymal Stromal Cells Treatment for Patients with Traumatic Brain Injury: A Safety and Effectiveness Trial

    Recruiting

    2 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    Italy

  • Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

    Recruiting

    3 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Spain

  • Study of GD2-CAR T Cells, Cyclophosphamide, and Fludarabine for Children with High-Risk or Relapsed Neuroblastoma and Other GD2+ Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • AUTOLOGOUS T CELLS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR AGAINST GD2, EX-VIVO EXPANDED
    • RIMIDUCID
    • Fludarabine Phosphate
    Italy

  • Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Study Comparing Isoflurane and Propofol for Sedation in Critically Ill Patients on Mechanical Ventilation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Isoflurane
    • Propofol
    Spain
Previous Page
1 … 251 252 253 254 255 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!